EX-99.1 2 s114111_ex99-1.htm EXHIBIT 99.1

Exhibit 99.1

 

GlyEco Reports Third Quarter and Nine Months Ended September 30, 2018 Results

 

High-Capacity Antifreeze Blending Facility Operational in WV with First Customer Shipment Completed

 

Q3 Results Impacted by Three Week Production Shutdown at WV Plant

 

ROCK HILL, SC / ACCESSWIRE / November 14, 2018 / GlyEco, Inc. (“GlyEco” or the “Company”) (OTC Pink: GLYE), a developer, manufacturer and distributor of performance fluids for the automotive, commercial and industrial markets, announced today the following financial results for the quarter and nine months ended September 30, 2018:

 

   Quarter ended Sept 30, 
   2018   2017 
         
Sales, net  $2,896,000   $3,285,000 
Gross profit  $163,000   $408,000 
Total operating expenses  $1,268,000   $2,163,000 
Loss from operations  $(1,104,000)  $(1,755,000)
Net loss  $(1,338,000)  $(2,057,000)
Adjusted EBITDA  $(713,000)  $(586,000)

 

   Nine Months ended Sept 30, 
   2018   2017 
         
Sales, net  $9,364,000   $8,493,000 
Gross profit  $1,110,000   $1,025,000 
Total operating expenses  $4,237,000   $4,370,000 
Loss from operations  $(3,127,000)  $(3,345,000)
Net loss  $(3,709,000)  $(4,068,000)
Adjusted EBITDA  $(1,939,000)  $(1,447,000)

 

Third Quarter of 2018 Highlights

 

Net revenues of $2.9 million were down 12% compared to $3.3 million for the same period last year.

 

oIndustrial Segment reported total revenues of $1.8 million and gross profit margin of 12%.

 

oConsumer Segment reported decreased total revenues of $1.4 million and gross loss of 4%.

 

Total gross profit was $163,000, or 6% of revenues, compared to $408,000, or 12% of revenues, for the same period last year.

 

Adjusted EBITDA, a non-GAAP measure, was $(713,000) compared to $(586,000) for the same period last year.

 

 

 

 

Third Quarter of 2018 Financial Review

 

The Company reported total revenues decreased by $389,000 or 12%, from $3,285,000 for the quarter ended September 30, 2017 to $2,896,000 for the quarter ended September 30, 2018. Consumer revenues decreased by $58,000 or 4%, from $1,456,000 for the quarter ended September 30, 2017 to $1,398,000 for the quarter ended September 30, 2018. The Consumer Segment remained focused on operational improvements and expense management during the quarter while deemphasizing retail sales growth. Industrial revenues decreased by $286,000 or 14%, from $2,077,000 for the quarter ended September 30, 2017 to $1,791,000 for the quarter ended September 30, 2018. During early August, the Company experienced an environmental issue related to the processing of feedstock at its Institute, WV facility, which resulted in the Company shutting down production at the facility. The issue was resolved with regulatory agencies, the landlord and site services provider, and feedstock suppliers during September and the net impact was 3-weeks of missed production at the facility. This impacted top-line revenue and gross margin for the quarter.

 

The Company reported total gross profit decreased from $408,000, representing a 12% gross margin, for the quarter ended September 30, 2017 to $163,000, representing a 6% gross margin, for the quarter ended September 30, 2018. Consumer gross profit decreased from $149,000, representing a 10% gross margin, for the quarter ended September 30, 2017 to negative ($49,000), representing a negative (4%) gross margin, for the quarter ended September 30, 2018. The Consumer gross profit was impacted by a decline in revenues as well as higher production costs due to total feedstock costs, including shipping costs, and certain non-recurring costs to improve long-term operations, including regulatory compliance expenses and facility improvements. Industrial gross profit decreased from $259,000, representing a 12% gross margin, for the quarter ended September 30, 2017 to $213,000, representing a 12% gross margin, for the quarter ended September 30, 2018. Industrial gross profit was impacted by decreased sales volume and a slight decrease in overall sales price.

 

The Company reported operating expenses decreased from $2,163,000, representing a 66% operating expense ratio for the quarter ended September 30, 2017, to $1,268,000, representing a 44% expense ratio for the quarter ended September 30, 2018. On a sequential basis, operating expenses decreased for the third consecutive quarter compared to $1,326,00 for the quarter ended June 30, 2018, $1,643,000 for the quarter ended March 31, 2018, and $1,594,000 for the quarter ended December 31, 2017. We expect that operating expenses will continue to decline incrementally over the coming quarters as significant non-recurring projects are completed, and we continue to refine our operations, including staff reductions and efficiencies from integrating our business segments.

 

The Company reported an operating loss of $1,104,000 for the quarter ended September 30, 2018, compared to a $1,755,000 operating loss for the quarter ended September 30, 2017.

 

 

 

 

The Company reported a net loss of $1,338,000 for the quarter ended September 30, 2018, compared to a net loss of $2,057,000 for the quarter ended September 30, 2017.

 

The Company reported adjusted EBITDA of $(714,000) for the quarter ended September 30, 2018, compared to $(586,000) for the quarter ended September 30, 2017.

 

Nine Months of 2018 Financial Review

 

The Company reported total revenues increased by $871,000 or 10%, from $8,493,000 for the nine months ended September 30, 2017 to $9,364,000 for the nine months ended September 30, 2018. Consumer revenues decreased by $156,000 or 3%, from $4,702,000 for the nine months ended September 30, 2017 to $4,546,000 for the nine months ended September 30, 2018. Industrial revenues increased $1,051,000 or 23%, from $4,626,000 for the nine months ended September 30, 2017 to $5,677,000 for the nine months ended September 30, 2018. Sales growth was significant in the Industrial Segment on a year over year basis and we expect continued growth in the coming quarters led by the Industrial Segment.

 

The Company reported total gross profit increased from $1,025,000, representing a 12% gross margin, for the nine months ended September 30, 2017 to $1,110,000, representing a 12% gross margin, for the nine months ended September 30, 2018. Consumer gross profit decreased from $609,000, representing a 13% gross margin, for the nine months ended September 30, 2017 to $32,000, representing a 1% gross margin, for the nine months ended September 30, 2018. The Consumer gross profit was impacted by a decline in revenues as well as higher production costs due to total feedstock costs, including shipping costs, and non-recurring costs to improve long-term operations, including severance, regulatory compliance expenses and facility improvements. Industrial gross profit increased from $416,000, representing a 9% gross margin, for the nine months ended September 30, 2017 to $1,077,000, representing a 19% gross margin, for the nine months ended September 30, 2018. Industrial gross profit was impacted by increased sales volume and a more profitable mix of business as well as scaling production at the Institute, West Virginia facility which remains well below its operational capacity.

 

The Company reported operating expenses decreased from $4,370,000, representing a 51% operating expense ratio for the nine months ended September 30, 2017, to $4,237,000, representing a 45% expense ratio for the nine months ended September 30, 2018. We expect that operating expenses will continue to decline incrementally over the coming quarters as significant non-recurring projects are completed, and we continue to refine our operations, including staff reductions and efficiencies from integrating our business segments.

 

The Company reported an operating loss of $3,127,000 for the nine months ended September 30, 2018, compared to a $3,345,000 operating loss for the nine months ended September 30, 2017.

 

 

 

 

The Company reported a net loss of $3,709,000 for the nine months ended September 30, 2018, compared to a net loss of $4,068,000 for the nine months ended September 30, 2017.

 

The Company reported adjusted EBITDA of $(1,939,000) for the nine months ended September 30, 2018, compared to $(1,447,000) for the nine months ended September 30, 2017.

 

Business Update

 

The antifreeze blending project at the facility in Institute, WV was completed, with the first customer delivery made in early November. The new facility provides the Company with capacity to blend up to 6 million gallons of finished antifreeze per year and facilitates large strategic partnerships for the future. The blending facility is directly supplied by our WV ethylene glycol plant and WEBA subsidiary allowing for full vertical-integration in antifreeze production. By moving our raw ethylene glycol downstream to blended products, like antifreeze, we can generate higher margins and mitigate the effect of price volatility in the ethylene glycol market.

 

“Our newly-realigned management team conducted a full strategic review during the quarter, reassessing the competitive advantages of the company and setting a go-forward strategy to best utilize our vertically-integrated production assets. A renewed focus on the production of raw materials at our West Virginia plant and the production of finished antifreeze at our recently-completed blending facility will drive growth and efficiencies in the months to come.” said Mr. Geib, our recently appointed President and Chief Executive Officer.

 

About GlyEco, Inc.

 

GlyEco is a developer, manufacturer and distributor of performance fluids for the automotive, commercial and industrial markets. We specialize in coolants, additives and complementary fluids. We believe our vertically integrated approach, which includes formulating products, acquiring feedstock, managing facility construction and upgrades, operating facilities, and distributing products through our fleet of trucks, positions us to serve our key markets and enables us to capture incremental revenue and margin throughout the process. Our network of facilities, develop, manufacture and distribute high quality products that meet or exceed industry quality standards, including a wide spectrum of ready to use antifreezes and additive packages for the antifreeze/coolant, gas patch coolants and heat transfer fluid industries, throughout North America. 

 

For further information, please visit: http://www.glyeco.com

 

To assist investors and other interested parties in staying informed about GlyEco, the Company distributes, by e-mail, press releases and other information. To be added to the Company distribution list, please contact us at info@glyeco.com.

 

 

 

 

Safe Harbor Statement

 

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements other than statements of historical facts included in this press release are forward-looking statements. In some cases, forward-looking statements can be identified by words such as “believe,” “expect,” “anticipate,” “plan,” “potential,” “continue,” or similar expressions. Such forward-looking statements include risks and uncertainties, and there are important factors that could cause actual results to differ materially from those expressed or implied by such forward-looking statements. These factors, risks and uncertainties are discussed in the Company’s filings with the Securities and Exchange Commission. Investors should not place any undue reliance on forward-looking statements since they involve known and unknown, uncertainties and other factors which are, in some cases, beyond the Company’s control which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects the Company’s current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to operations, results of operations, growth strategy and liquidity. The Company assumes no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future, except as required by federal securities laws.

 

Contact:

 

GlyEco, Inc.

Brian Gelman

Corporate EVP and Chief Financial Officer

bgelman@glyeco.com

866-960-1539

 

SOURCE: GlyEco, Inc.

 

 

 

 

GLYECO, INC. AND SUBSIDIARIES

Condensed Consolidated Balance Sheets

September 30, 2018 and December 31, 2017

 

   September 30,   December 31, 
   2018   2017 
   (unaudited)      
ASSETS          
           
Current Assets          
Cash  $230,771   $111,302 
Cash - restricted       6,642 
Accounts receivable, net   1,043,465    1,546,367 
Prepaid expenses   198,630    360,953 
Inventories   546,543    564,133 
Total current assets   2,019,409    2,589,397 
           
Property, plant and equipment, net   3,951,291    3,897,950 
           
Other Assets          
Deposits   403,502    436,450 
Goodwill   3,822,583    3,822,583 
Other intangible assets, net   1,898,987    2,266,654 
Total other assets   6,125,072    6,525,687 
           
Total assets  $12,095,772   $13,013,034 
           
LIABILITIES AND STOCKHOLDERS’ EQUITY          
           
Current Liabilities          
Accounts payable and accrued expenses  $3,439,931   $2,921,406 
Contingent acquisition consideration   1,503,113    1,509,755 
Notes payable – current portion, net of debt discount   2,063,228    297,534 
Capital lease obligations – current portion   480,217    377,220 
Total current liabilities   7,486,489    5,105,915 
           
Non-Current Liabilities          
Notes payable – non-current portion   2,924,149    2,953,631 
Capital lease obligations – non-current portion   878,667    1,085,985 
Total non-current liabilities   3,802,816    4,039,616 
           
Total liabilities   11,289,305    9,145,531 
           
Commitments and Contingencies          
           
Stockholders’ Equity          
Preferred stock, par value $0.0001 per share: 40,000,000 shares authorized; no shares issued and outstanding as of  September 30, 2018 and December 31, 2017, respectively        
Common stock, par value $0.0001 per share: 300,000,000 shares authorized; 1,348,253 and 1,322,304 shares issued and outstanding as of September 30, 2018 and December 31, 2017, respectively   135    132 
Additional paid-in capital   46,511,861    45,863,969 
Accumulated deficit   (45,705,529)   (41,996,598)
Total stockholders’ equity   806,467    3,867,503 
           
Total liabilities and stockholders’ equity  $12,095,772   $13,013,034 

 

 

 

 

GLYECO, INC. AND SUBSIDIARIES

Condensed Consolidated Statements of Operations

For the three and nine months ended September 30, 2018 and 2017

 

   Three months ended
September 30,
   Nine months ended
September 30,
 
   2018   2017   2018   2017 
   (unaudited)   (unaudited)   (unaudited)   (unaudited) 
                 
Sales, net  $2,895,758   $3,284,670   $9,364,148   $8,493,088 
Cost of goods sold   2,732,548    2,876,577    8,254,589    7,468,406 
Gross profit   163,210    408,093    1,109,559    1,024,682 
                     
Operating expenses:                    
Consulting fees   18,367    149,233    92,511    368,195 
Share-based compensation   107,054    129,707    348,515    361,241 
Salaries and wages   513,821    539,651    1,730,234    1,246,252 
Legal and professional   211,208    152,797    752,688    501,528 
Tank remediation       780,000        780,000 
General and administrative   417,237    411,966    1,312,667    1,112,307 
Total operating expenses   1,267,687    2,163,354    4,236,615    4,369,523 
                     
Loss from operations   (1,104,477)   (1,755,261)   (3,127,056)   (3,344,841)
                     
Other expenses:                    
Loss on debt extinguishment       146,564        146,564 
Interest expense   240,864    154,068    572,140    573,671 
Total other expense, net   240,864    300,632    572,140    720,235 
                     
Loss before provision for (benefit from) income taxes   (1,345,341)   (2,055,893)   (3,699,196)   (4,065,076)
                     
Provision for (benefit from) income taxes   (7,516)   653    9,735    2,606 
                     
Net loss  $(1,337,825)  $(2,056,546)  $(3,708,931)  $(4,067,682)
                     
Basic and diluted loss per share  $(1.00)  $(1.73)  $(2.78)  $(3.77)
                     
Weighted average number of common shares outstanding - basic and diluted   1,343,029    1,189,818    1,333,131    1,077,673 

 

 

 

 

GLYECO, INC. AND SUBSIDIARIES

Adjusted Earnings before Interest, Taxes, Depreciation and Amortization (non-GAAP)

For the three and nine months ended September 30, 2018 and 2017

 

   Three Months Ended
September 30,
 
   2018   2017 
GAAP net loss  $(1,337,825)  $(2,056,546)
           
Interest expense   240,864    154,068 
Loss on debt extinguishment       146,564 
Tank remediation       780,000 
Income tax (benefit) expense   (7,516)   653 
Depreciation and amortization   284,186    259,130 
Share-based compensation   107,054    129,707 
Adjusted EBITDA  $(713,237)  $(586,424)

 

   Nine Months Ended
September 30,
 
   2018   2017 
GAAP net loss  $(3,708,931)  $(4,067,682)
           
Interest expense   572,140    573,671 
Loss on debt extinguishment       146,564 
Tank Remediation       780,000 
Income tax expense   9,735    2,606 
Depreciation and amortization   839,097    756,517 
Share-based compensation   348,515    361,241 
Adjusted EBITDA  $(1,939,444)  $(1,447,083)

 

Presented above is the non-GAAP financial measure representing earnings before interest, taxes, depreciation, amortization and stock compensation (which we refer to as “Adjusted EBITDA”) and the reconciliations of Adjusted EBITDA to net loss. Adjusted EBITDA should be viewed as supplemental to, and not as an alternative for, net income (loss) and cash flows from operations calculated in accordance with GAAP.

 

Adjusted EBITDA is used by our management as an additional measure of our Company’s performance for purposes of business decision-making, including developing budgets, managing expenditures, and evaluating potential acquisitions or divestitures. Period-to-period comparisons of Adjusted EBITDA help our management identify additional trends in our Company’s financial results that may not be shown solely by period-to-period comparisons of net income (loss) and cash flows from operations. In addition, we may use Adjusted EBITDA in the incentive compensation programs applicable to many of our employees in order to evaluate our Company’s performance. Further, we believe that the presentation of Adjusted EBITDA is useful to investors in their analysis of our results and helps investors make comparisons between our company and other companies that may have different capital structures, different effective income tax rates and tax attributes, different capitalized asset values and/or different forms of employee compensation. Our management recognizes that Adjusted EBITDA has inherent limitations because of the excluded items, particularly those items that are recurring in nature. In order to compensate for those limitations, management also reviews the specific items that are excluded from Adjusted EBITDA, but included in net income (loss), as well as trends in those items.